Skip to main content
SpringerLink
Log in

Alemtuzumab/varicella-zoster-virus-vaccine-live

Chicken pox, asymptomatic COVID and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Habek M. Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis. Neurological Sciences 42: 4003-4005, No. 10, Oct 2021. Available from: URL: http://doi.org/10.1007/s10072-021-05495-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab/varicella-zoster-virus-vaccine-live. Reactions Weekly 1884, 28 (2021). https://doi.org/10.1007/s40278-021-06349-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06349-7

Search

Navigation